PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Research Center, Department of Internal Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.\', \'Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.\', \'Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Nanobiotechnology, New Technologies Research Group, Pasteur Institute, Tehran, Iran.\', \'Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Chatham-Maritime, Kent ME4 4TB, UK.\', \'Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: rezabakhsha@tbzmed.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-5769(21)00893-610.1016/j.intimp.2021.108257
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34673299
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34673299>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34673299>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all